Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy.

Q3 Medicine

Recent patents on anti-infective drug discovery Pub Date : 2017-01-01 DOI:10.2174/1574891X12666170425122416

Mohammad T Athar, Zabih Ullah

引用次数: 2

Abstract

Background: Tuberculosis (TB), which is caused by the Mycobacterium tuberculosis, is a serious threat and one of the major health problems worldwide.

Objective: In recent years, an estimated of 9.6 million TB cases occurred and 1.5 million death occurred due to TB worldwide.

Conclusion: The present review is an attempt to introduce this disease focusing on the pathophysiology of the disease, the current approaches and the related patents for treatment and the future planning for combating this disease.

查看原文本刊更多论文

纳米医学在结核病治疗中的应用现状与展望。

背景:结核病是由结核分枝杆菌引起的一种严重威胁，是世界范围内的主要健康问题之一。目的:近年来，全球估计发生了960万例结核病病例，150万人死于结核病。结论:本文对本病的病理生理、目前的治疗途径、相关专利及今后的防治计划等方面进行了综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Recent patents on anti-infective drug discovery Medicine-Pharmacology (medical)

CiteScore

2.40

自引率

0.00%

发文量

期刊介绍： Recent Patents on Anti-Infective Drug Discovery publishes review articles on recent patents in the field of anti-infective drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery.